These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19851626)

  • 1. Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program.
    do Lago RF; Costa Ndo R
    Cad Saude Publica; 2009 Oct; 25(10):2273-84. PubMed ID: 19851626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
    Nunn AS; Fonseca EM; Bastos FI; Gruskin S; Salomon JA
    PLoS Med; 2007 Nov; 4(11):e305. PubMed ID: 18001145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expert communities and interest-formation in the Brazilian AIDS program.
    Lago RFD; Costa NDR
    Cien Saude Colet; 2017 May; 22(5):1479-1488. PubMed ID: 28538919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Health care to HIV/AIDS patients in Brazil].
    Portela MC; Lotrowska M
    Rev Saude Publica; 2006 Apr; 40 Suppl():70-9. PubMed ID: 16729161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sustainability of Brazilian policy for access to antiretroviral drugs].
    Grangeiro A; Teixeira L; Bastos FI; Teixeira P
    Rev Saude Publica; 2006 Apr; 40 Suppl():60-9. PubMed ID: 16729160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Brazilian policy for the distribution and production of antiretroviral drugs: a privilege or a right?].
    Galvao J
    Cad Saude Publica; 2002; 18(1):213-9. PubMed ID: 11910440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brazil and access to HIV/AIDS drugs: a question of human rights and public health.
    Galvão J
    Am J Public Health; 2005 Jul; 95(7):1110-6. PubMed ID: 15933238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?
    Benzaken AS; Pereira GFM; Costa L; Tanuri A; Santos AF; Soares MA
    AIDS Res Ther; 2019 Aug; 16(1):19. PubMed ID: 31412889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly active antiretroviral therapy in Brazil: the challenge of universal access in a context of social inequality.
    Hacker MA; Petersen ML; Enriquez M; Bastos FI
    Rev Panam Salud Publica; 2004 Aug; 16(2):78-83. PubMed ID: 15357932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
    Cohen J
    Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
    [No Abstract]   [Full Text] [Related]  

  • 11. Access to antiretroviral drugs in Brazil.
    Galvão J
    Lancet; 2002 Dec; 360(9348):1862-5. PubMed ID: 12480377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmaceutical patents and public health: challenges for the Brazilian antiretroviral treatment policy].
    Meiners CM
    Cad Saude Publica; 2008 Jul; 24(7):1467-78. PubMed ID: 18670671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives.
    Greco DB; Simão M
    AIDS; 2007 Jul; 21 Suppl 4():S37-45. PubMed ID: 17620751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Brazilian experiment: HIV drugs for all.
    Flaer PJ; Younis MZ
    J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy supply chain quality control and assurance in improving people living with HIV therapeutic outcomes in Cameroon.
    Djobet MP; Singhe D; Lohoue J; Kuaban C; Ngogang J; Tambo E
    AIDS Res Ther; 2017 Apr; 14(1):19. PubMed ID: 28376825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustainability of ARV provision in developing countries: challenging a framework based on program history.
    Azeredo TB; Oliveira MA; Santos-Pinto CDB; Miranda ES; Osorio-de-Castro CGS
    Cien Saude Colet; 2017 Aug; 22(8):2581-2594. PubMed ID: 28793074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making tenofovir accessible in the brazilian public health system: patent conflicts and generic production.
    Veras J
    Dev World Bioeth; 2014 Aug; 14(2):92-100. PubMed ID: 24889312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to antiretroviral treatment in Latin American countries and the Caribbean.
    Chequer P; Cuchí P; Mazin R; García Calleja JM
    AIDS; 2002 Dec; 16 Suppl 3():S50-7. PubMed ID: 12685925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing global essential medicines norms to improve access to AIDS treatment: lessons from Brazil.
    Nunn A; Fonseca ED; Gruskin S
    Glob Public Health; 2009; 4(2):131-49. PubMed ID: 19333805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV/AIDS: Latin America & Caribbean. Peru: universal access: more goal than reality.
    Cohen J
    Science; 2006 Jul; 313(5786):489. PubMed ID: 16873658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.